Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Promoting Self-Management in Head and Neck Cancer Survivors With Lymphedema and Fibrosis [PROMISE Trial]
Abramson Cancer Center at Penn Medicine
204 participants
Mar 29, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will conduct self-care activities prescribed by their treating lymphedema therapists.
Participants will receive the in-person LEF-SMP intervention.
Participants will receive the telehealth LEF-SMP intervention.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06125743